Evelyn Partners Investment Management Europe Ltd Sells 2,225 Shares of UnitedHealth Group Incorporated $UNH

Evelyn Partners Investment Management Europe Ltd trimmed its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 65.7% during the 1st quarter, HoldingsChannel reports. The institutional investor owned 1,161 shares of the healthcare conglomerate’s stock after selling 2,225 shares during the period. Evelyn Partners Investment Management Europe Ltd’s holdings in UnitedHealth Group were worth $314,000 as of its most recent SEC filing.

Several other large investors also recently made changes to their positions in the stock. Sarver Vrooman Wealth Advisors acquired a new position in UnitedHealth Group during the fourth quarter valued at approximately $25,000. Anfield Capital Management LLC boosted its holdings in shares of UnitedHealth Group by 220.0% during the 4th quarter. Anfield Capital Management LLC now owns 80 shares of the healthcare conglomerate’s stock worth $26,000 after buying an additional 55 shares during the period. Joseph Group Capital Management acquired a new position in UnitedHealth Group in the 4th quarter valued at $27,000. Nalls Sherbakoff Group LLC acquired a new position in UnitedHealth Group during the 4th quarter worth $27,000. Finally, Lifetime Wealth Management P.C. bought a new stake in UnitedHealth Group during the fourth quarter valued at about $29,000. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Down 0.9%

NYSE UNH opened at $416.89 on Tuesday. UnitedHealth Group Incorporated has a 1-year low of $234.60 and a 1-year high of $461.62. The company has a current ratio of 0.78, a quick ratio of 0.80 and a debt-to-equity ratio of 0.66. The stock’s 50 day moving average is $408.53 and its two-hundred day moving average is $346.11. The company has a market capitalization of $378.59 billion, a price-to-earnings ratio of 26.83, a PEG ratio of 1.46 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Thursday, July 16th. The healthcare conglomerate reported $6.38 EPS for the quarter, topping the consensus estimate of $4.94 by $1.44. UnitedHealth Group had a return on equity of 16.53% and a net margin of 3.14%.The business had revenue of $112.03 billion during the quarter, compared to the consensus estimate of $110.81 billion. During the same quarter last year, the company earned $4.08 EPS. UnitedHealth Group’s revenue was up .4% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. Equities analysts forecast that UnitedHealth Group Incorporated will post 19.69 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, June 23rd. Investors of record on Monday, June 15th were given a dividend of $2.32 per share. This is an increase from UnitedHealth Group’s previous quarterly dividend of $2.21. The ex-dividend date was Monday, June 15th. This represents a $9.28 dividend on an annualized basis and a dividend yield of 2.2%. UnitedHealth Group’s dividend payout ratio is 59.72%.

Wall Street Analyst Weigh In

A number of research firms have issued reports on UNH. TD Cowen raised their target price on UnitedHealth Group from $337.00 to $430.00 and gave the company a “hold” rating in a report on Tuesday, July 14th. Leerink Partners raised their price objective on shares of UnitedHealth Group from $400.00 to $462.00 and gave the stock an “outperform” rating in a research note on Wednesday, June 17th. Bank of America reiterated a “buy” rating on shares of UnitedHealth Group in a research note on Monday, July 20th. Cantor Fitzgerald restated an “overweight” rating on shares of UnitedHealth Group in a report on Thursday, June 11th. Finally, Erste Group Bank upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Monday, April 27th. Two equities research analysts have rated the stock with a Strong Buy rating, twenty have assigned a Buy rating and five have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $455.92.

UnitedHealth Group Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.